Chantibody Therapeutics

Chantibody Therapeutics is focusing on discovery and development of transformational therapeutics for unmet medical needs in life-threatening diseases especially cancer. We’ve developed a proprietary AI-guided antibody discovery platform, as a solid foundation for innovative biologics with diverse formats (e.g. mAb, bispecific antibody and fusion proteins), and other diverse modalities such as mRNA, CART, and antibody conjugates. Well-funded and supported by our unique research, development, and clinical validation ecosystem under our corporate umbrella, the team encompasses industry veterans with proven track records of generating novel biologics to global clinical trials.